Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Luca Benatti

At a glance: Luca Benatti is Director at Quince Therapeutics (QNCX). Their latest SEC Form 4, filed Dec 29, 2025, reported a sale of $35.6M. On file: 0 purchase lines ($0) and 1 sale line ($35.6M).

Disclosed holdings: about $1.6M of QNCX stock: 39,179 shares reported on their latest Form 4 (filed Dec 29, 2025), valued at the Nov 18, 2026 close of $40.59. This counts only QNCX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Quince Therapeutics, Inc. (QNCX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $35.6M

Reported trades

Filed Stock Type Shares Price Value Since
Dec 29SEC QNCXQuince Therapeutics, Inc. Sell 50,00039,179 held (−56%) $712.00 $35.6M -94.3%
  • Sell

    Director Luca Benatti sold $35.6M of QNCX at $712.00 — cuts the stake by 56%.

Follow Luca Benatti

Get one email when Luca Benatti files a new purchase or sale. Free.

At most one email a day about Luca Benatti, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.